Business Context and Reporting Period
This Form 6-K filing by MDxHealth SA (NASDAQ: MDXH) covers the month of May 2024, with a specific reporting date of May 6, 2024. The document serves as a report of a foreign private issuer pursuant to Rule 13a-16 under the Securities Exchange Act of 1934.
Key Financial Metrics
The filing does not provide financial statements, revenue, profit, cash flow, margins, debt, or liquidity metrics. The document is exclusively focused on a corporate governance event regarding executive share ownership.
Material Changes
The primary material event disclosed is the purchase of company stock by the Chief Executive Officer. On May 3, 2024, Michael McGarrity purchased 45,000 ordinary shares of MDxHealth SA for a total aggregate price of approximately $140,000.
Guidance, Outlook, and Risks
The filing contains no financial guidance, operational outlook, or discussion of risks and contingencies. It includes a standard disclaimer stating that the information is furnished and not "filed" for purposes of Section 18 of the Exchange Act, nor is it incorporated by reference into other filings unless expressly stated. The text notes that Mr. McGarrity is not generally required to disclose his trading activity outside of limited circumstances.
Investor Verification Checklist
- Verify the exact number of shares purchased (45,000) and the total cost (~$140,000) by Michael McGarrity.
- Confirm the transaction date of May 3, 2024.
- Review the Company's Annual Report on Form 20-F for broader context on executive compensation and ownership policies.
- Note that this filing does not contain updated financial performance data.